These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31118607)

  • 1. Gold nanoparticle uptake is enhanced by estradiol in MCF-7 breast cancer cells.
    Lara-Cruz C; Jiménez-Salazar JE; Arteaga M; Arredondo M; Ramón-Gallegos E; Batina N; Damián-Matsumura P
    Int J Nanomedicine; 2019; 14():2705-2718. PubMed ID: 31118607
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing roughness of the human breast cancer cell membrane through incorporation of gold nanoparticles.
    Lara-Cruz C; Jiménez-Salazar JE; Ramón-Gallegos E; Damian-Matsumura P; Batina N
    Int J Nanomedicine; 2016; 11():5149-5161. PubMed ID: 27785020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolvin D2 supports MCF-7 cell proliferation via activation of estrogen receptor.
    Al-Zaubai N; Johnstone CN; Leong MM; Li J; Rizzacasa M; Stewart AG
    J Pharmacol Exp Ther; 2014 Oct; 351(1):172-80. PubMed ID: 25077525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid Probes Conjugated with Protein-Protected Gold Nanocluster: Specific and Rapid Fluorescence Imaging of Steroid Receptors in Target Cells.
    Tsai CY; Li CW; Li JR; Jang BH; Chen SH
    J Fluoresc; 2016 Jul; 26(4):1239-48. PubMed ID: 27165037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dioxin and 17β-estradiol on the expression of cytochrome P450 1A1 gene via an estrogen receptor dependent pathway in cellular and xenografted models.
    Go RE; Hwang KA; Kim CW; Byun YS; Nam KH; Choi KC
    Environ Toxicol; 2017 Oct; 32(10):2225-2233. PubMed ID: 28618207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photothermal therapeutic response of cancer cells to aptamer-gold nanoparticle-hybridized graphene oxide under NIR illumination.
    Yang L; Tseng YT; Suo G; Chen L; Yu J; Chiu WJ; Huang CC; Lin CH
    ACS Appl Mater Interfaces; 2015 Mar; 7(9):5097-106. PubMed ID: 25705789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action of estra-1,3,5(10)-triene-3, 17 beta-diol, 3-benzoate, 17[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy] acetate] (KM2210) on MCF-7 human breast tumours transplanted into nude mice.
    Kubota T; Ishibiki K; Abe O; Kosano H; Ohsawa N; Hoffman RM
    Anticancer Res; 1993; 13(4):935-40. PubMed ID: 8352562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludioxonil induced the cancer growth and metastasis via altering epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in cellular and xenografted breast cancer models.
    Go RE; Kim CW; Jeon SY; Byun YS; Jeung EB; Nam KH; Choi KC
    Environ Toxicol; 2017 Apr; 32(4):1439-1454. PubMed ID: 27539251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells.
    Rai D; Frolova A; Frasor J; Carpenter AE; Katzenellenbogen BS
    Mol Endocrinol; 2005 Jun; 19(6):1606-17. PubMed ID: 15831524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 17β-estradiol on estrogen receptor negative breast cancer cells in an osteolytic mouse model.
    Cohen DJ; Patel V; Verma A; Boyan BD; Schwartz Z
    Steroids; 2019 Feb; 142():28-33. PubMed ID: 29133279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer.
    Robertson JF; Nicholson RI; Bundred NJ; Anderson E; Rayter Z; Dowsett M; Fox JN; Gee JM; Webster A; Wakeling AE; Morris C; Dixon M
    Cancer Res; 2001 Sep; 61(18):6739-46. PubMed ID: 11559545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
    Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
    Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
    Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
    Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
    Duan R; Porter W; Safe S
    Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
    Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
    Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-independent activation of estrogen receptor function by 3, 3'-diindolylmethane in human breast cancer cells.
    Riby JE; Chang GH; Firestone GL; Bjeldanes LF
    Biochem Pharmacol; 2000 Jul; 60(2):167-77. PubMed ID: 10825461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of the procarcinogenic 17β-estradiol on nutrient uptake by the MCF-7 breast cancer cell line.
    Nunes C; Silva C; Correia-Branco A; Martel F
    Biomed Pharmacother; 2017 Jun; 90():287-294. PubMed ID: 28365520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of low concentrations of phthalates on the effects of 17β-estradiol in MCF-7 breast cancer cells.
    Chen FP; Chien MH; Chern IY
    Taiwan J Obstet Gynecol; 2016 Dec; 55(6):826-834. PubMed ID: 28040128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, (177)Lu.
    Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM
    Mol Pharm; 2015 Nov; 12(11):3963-72. PubMed ID: 26402157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.